News Roundup: EUA Pfizer Booster for Teens, Contraceptive Program

Here’s a roundup of the latest news from Drug Topics®.

Breaking: FDA Amends Pfizer-BioNTech COVID-19 Vaccine EUA to Allow Booster Doses for Adolescents

Individuals aged 16 or 17 years may now receive a single booster dose at least 6 months after completion of their primary vaccination series.

https://www.drugtopics.com/view/breaking-fda-amends-pfizer-biontech-covid-19-vaccine-eua-to-allow-booster-doses-for-adolescents

Addition of Pharmacists to Diabetes Management Teams Enhances Care

The addition of a pharmacist to a diabetes management team increases therapy optimization and medication access while enhancing patient care

https://www.drugtopics.com/view/addition-of-pharmacists-to-diabetes-management-teams-enhances-care

ThoughtSpot 2021: Global Independent Pharmacy Trends

As part of our ThoughtSpot 2021 podcast series, guest host Jenni Zilka, President of Good Neighbor Pharmacy, leads a conversation on global trends in independent pharmacy across the US and Europe.

https://www.drugtopics.com/view/thoughtspot-2021-global-independent-pharmacy-trends

Update: 2021-2022 Flu Season

Influenza is expected to make a comeback this year, and no one knows how severe it may be.

https://www.drugtopics.com/view/update-2021-2022-flu-season

Evaluating Analgesic Use During COVID-19

Mean days of therapy per 1000 patient-days were reduced across medication categories.

https://www.drugtopics.com/view/evaluating-analgesic-use-during-covid-19

Pharmacist Prescribed Contraceptive Access Program Successful

Patients in California were able to receive a contraceptive prescription during a visit with a pharmacist.

https://www.drugtopics.com/view/pharmacist-prescribed-contraceptive-access-program-successful

Study: Increasing Naloxone Access Improves Opioid Outcomes

Study findings presented at the 2021 ASHP Midyear Clinical Meeting & Exhibition revealed naloxone counseling can impact the opioid crisis through patient education.

https://www.drugtopics.com/view/study-increasing-naloxone-access-improves-opioid-outcomes